Clinical Pharmacology for the Office of Medicare Hearings and Appeals

The PSC Financial Management and Procurement Portfolio is issuing a pre-solicitation for clinical pharmacology compendia licenses for the Office of Medicare Hearings and Appeals (OMHA). The agency plans to award a sole-source contract to Elsevier Inc. for medical compendia used by Administrative Law Judges and attorneys to evaluate Medicare Part B anti-cancer drug coverage. This procurement, under FAR 13.106-1(b), covers 32 licenses to support legal and medical reviews. The contract includes a 12-month base period and four 12-month options. While a primary source is identified, the government will accept capability statements to determine if a competitive procurement is necessary. Responses are due by June 23, 2026. The Office of the Assistant Secretary for Administration (ASA) is procuring clinical pharmacology compendia licenses for OMHA. These licenses provide Administrative Law Judges and attorneys with medical data for Medicare Part B anti-cancer drug coverage decisions. The government intends to award a sole-source contract to Elsevier Inc. under FAR 13.106-1(b). OMHA needs 32 licenses to support Medicare Part B claim adjudication. This resource helps Administrative Law Judges and attorneys determine coverage for anti-cancer therapies. The database includes information on over 50,000 products, such as FDA-approved medicines, over-the-counter drugs, supplements, and investigational agents.